|
Market Closed -
Nasdaq
16:00:00 2024-12-23 EST
|
5-day change | 1st Jan Change | ||
| 0.2531 USD | +4.20% |
|
-.--% | - |
| 07-23 | Scancell Holdings plc agreed to acquire Neuphoria Therapeutics Inc. for $35 million. | CI |
| 07-23 | Neuphoria Therapeutics Agrees to All-Share Takeover by Scancell | MT |
Evolution of the Average Target: BIONOMICSSADR
Evolution of the Target Price: BIONOMICSSADR
Changes in Analyst Recommendations: BIONOMICSSADR
cdbcc2dbc6f20a9286e7e.9D0Wf57JoYqQFLYcND9oXa9vkXZf56ff-okNWpS72UU.xnNgDdi9zfz3dfN_blEJD55b5Qc3ndSvtOtBHM74i3OETlwt9_nbuPRs4w~fdaf35437eae1cea6f71841a6b904ee7
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +20.94% | |||||
| +19.26% | |||||
| +3.18% | |||||
| +20.63% | |||||
| +42.28% | |||||
| +16.3% | |||||
| -1.6% | |||||
| -0.26% | |||||
| -2.6% | |||||
| Average | +13.12% | |||||
| Weighted average by Cap. | +16.41% |
Analysts' Consensus
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3.770
Average target price
-
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- NEUP Stock
- BNOX Stock
- Consensus BIONOMICSSADR
Select your edition
All financial news and data tailored to specific country editions
